Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1634209

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1634209

Latin America Liposomal Vitamins and Minerals Market - 2024 - 2032

PUBLISHED:
PAGES: 169 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3750
PDF & Excel (Multiple User License)
USD 4000
PDF & Excel (Enterprise License)
USD 7250

Add to Cart

The Latin America liposomal vitamins and minerals market reached US$40.78 million in 2023 and is expected to reach US$64.54 million by 2032, growing at a CAGR of 5.3% during the forecast period 2024-2032.

Liposomes are small vesicles made up of phospholipid bilayer and are widely used in pharmaceutical applications for drug delivery. Vitamins and minerals are encapsulated in liposomes to enhance their stability, protect them from the gastrointestinal environment, and improve their overall absorption.

The liposomes which resemble the natural cell membrane enable vitamins and minerals to enter the bloodstream directly, and then into cells ensuring higher bioavailability, as compared to traditional formulations. Almost all the fat-soluble vitamins, water-soluble vitamins, and minerals can be delivered into the body using liposomal carriers.

Market Dynamics: Drivers & Restraints

Rising Chronic Diseases and Improving Health Trends

The market for liposomal vitamins and minerals is expected to be significantly driven by the rising chronic diseases and improving health trends in the Latin america region. Latin America is a region with a high prevalence of non-communicable diseases such as obesity, diabetes, and heart conditions. As per the UNICEF (The United Nations International Children's Emergency Fund) report published in May 2023, Latin America and the Caribbean have the highest rates of overweight and obesity in the world, with an adult obesity prevalence rate of 24.2%, and 50% of the adult population is overweight. This higher prevalent population is at a significant risk of life-threatening cardiovascular conditions.

Nutritional supplements play a crucial role in these populations, aiding their overall health and well-being. This population can provide a significant opportunity for market expansion of liposomal vitamins and minerals.

Moreover, In Latin America, the consumption of nutritional supplements is higher among only specific demographics such as health enthusiasts, sports personnel, athletes, and those living in urban areas.

A study published in the Springer Nature Journal in January 2024 stated that nearly 90% of surveyed Brazilian male recreational triathletes have reported the consumption of at least one dietary supplement regularly.

Liposomal vitamins and minerals being the advanced formulations, their adoption rate is anticipated to improve among these specific populations, with a history of frequent consumption.

Among the general population, the adoption of liposomal vitamins and minerals is expected to grow due to rising awareness of the health benefits of regular dietary supplements. Intervening these populations with the advanced liposomal formulation can trigger the adoption and propel the market growth in the forecast period.

Limited consumer awareness of liposomal vitamins and minerals may restrain the market growth.

Although the consumer base for dietary supplements is high in Latin America, the adoption rate of vitamins and minerals made using advanced liposomal technology is lower. This is due to a lack of awareness, which is especially high in certain population groups living in rural areas who may have less access to these dietary supplements and may be unaware of their existence. Moreover, the majority of liposomal vitamins and minerals brands are imported into Latin American countries, and only a limited number of indigenous manufacturers are present. This limits the availability of these dietary supplements to only specific parts of the region.

For more details on this report - Request for Sample

Segment Analysis

The Latin America Liposomal vitamins and minerals market is segmented based on product type, dosage form, and country.

Vitamins in the product type segment have the highest market share in the Latin America liposomal vitamins and minerals market.

Vitamins are the most commonly used dietary supplements in Latin America and across the globe. All the vitamins are essential micronutrients, and they play a crucial role in maintaining overall health and well-being. The human body cannot produce the majority of the vitamins, and to maintain proper functioning, they must be obtained from external sources like diet and supplementation.

Globally, the trend of dietary supplement consumption is increasing, which is drastically propelled by the Covid-19 pandemic. Many people across the world have seen the health benefits of regular dietary supplementations. A study published in the Nutrients journal in July 2023, has stated that COVID-19 has propelled dietary supplement consumption, and among these multivitamins have gained huge traction. The same trends are observed across the world including Latin America. However, a study published in the SciELO - Scientific Electronic Library Online in September 2023 has stated that multivitamins are the most widely consumed dietary supplements in the urban areas of Brazil.

This signifies the higher penetration of vitamin supplements in the Latin America market, which also paves the way for liposomal vitamin growth in the forecasted period.

Competitive Landscape

The major Latin America players in the Liposomal vitamins and minerals market are Kemed, Biocyte Laboratoire, Erewhon, NOW Foods, Codeage LLC, LivOn Labs, NutriFlair, Natusvita Industria de Suplementos Nutricionais Ltda., Ture Source and Beyond Vitamins among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and Product Type pipelines, and forecasts upcoming pharmaceutical advancements.
  • Product Type Performance & Market Positioning: Analyzes Product Type performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into Product Type development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Product Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance Product Type safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Latin America liposomal vitamins and minerals market report would provide approximately 57 tables, 46 figures, and 155 pages.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.
Product Code: PH9009

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Dosage Form
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Chronic Diseases and Improving Health Trends
      • 4.1.1.2. Large Consumer Base
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Consumer Awareness
    • 4.1.3. Opportunities
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Pipeline Analysis
  • 5.5. Patent Analysis
  • 5.6. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Vitamins*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Vitamin A
    • 6.2.4. Vitamin B
    • 6.2.5. Vitamin C
    • 6.2.6. Vitamin D
    • 6.2.7. Vitamin E
  • 6.3. Minerals
    • 6.3.1. Iron
    • 6.3.2. Zinc
    • 6.3.3. Magnesium
    • 6.3.4. Copper
    • 6.3.5. Others

7. By Dosage Form

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
    • 7.1.2. Market Attractiveness Index, By Dosage Form
  • 7.2. Capsules*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Tablets
  • 7.4. Gummies
  • 7.5. Sachets
  • 7.6. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. Latin America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage Form
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.5.1. Mexico
      • 8.2.5.2. Brazil
      • 8.2.5.3. Argentina
      • 8.2.5.4. Colombia
      • 8.2.5.5. Peru
      • 8.2.5.6. Rest of Latin America

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. Kemed*
    • 10.1.1. Company Overview
    • 10.1.2. Product Type Portfolio and Description
    • 10.1.3. Financial Overview
    • 10.1.4. Key Developments
  • 10.2. Biocyte Laboratoire
  • 10.3. Erewhon
  • 10.4. NOW(R) Foods
  • 10.5. Codeage LLC
  • 10.6. LivOn Labs
  • 10.7. NutriFlair
  • 10.8. Natusvita Industria de Suplementos Nutricionais Ltda.
  • 10.9. Ture Source
  • 10.10. Beyond Vitamins

LIST NOT EXHAUSTIVE

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!